Drug Shortage Report for APO-CEPHALEX

Last updated on 2024-01-12 History
Report ID 197876
Drug Identification Number 00768723
Brand name APO-CEPHALEX
Common or Proper name APO-CEPHALEX
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) CEPHALEXIN
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 BTL
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-07-05
Estimated end date 2024-01-19
Actual end date 2024-01-11
Shortage status Resolved
Updated date 2024-01-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-01-12 French Compare
v12 2024-01-12 English Compare
v10 2024-01-05 English Compare
v11 2024-01-05 French Compare
v9 2024-01-05 English Compare
v8 2023-12-08 French Compare
v7 2023-12-08 English Compare
v6 2023-10-20 French Compare
v5 2023-10-20 English Compare
v4 2023-07-13 French Compare
v3 2023-07-13 English Compare
v2 2023-07-07 French Compare
v1 2023-07-07 English Compare

Showing 1 to 13 of 13